ATC-0175

From WikiMD's WELLNESSPEDIA

ATC-0175_structure.png

== ATC-0175 ==

ATC-0175 is a pharmaceutical drug that falls under the category of antineoplastic agents. It is primarily used in the treatment of various types of cancer. The drug works by inhibiting the growth and proliferation of cancer cells, thereby slowing down or stopping the progression of the disease.

Mechanism of Action[edit]

ATC-0175 functions by targeting specific cellular pathways that are essential for cancer cell survival and replication. It interferes with the DNA replication process, leading to cell cycle arrest and apoptosis of the malignant cells. This mechanism is similar to other chemotherapeutic agents that aim to disrupt the cell cycle of rapidly dividing cells.

Indications[edit]

ATC-0175 is indicated for the treatment of several types of cancer, including but not limited to:

Administration[edit]

The drug is typically administered through intravenous injection under the supervision of a qualified healthcare professional. The dosage and frequency of administration depend on the type and stage of cancer, as well as the patient's overall health and response to the treatment.

Side Effects[edit]

Common side effects of ATC-0175 include:

Patients are advised to report any severe or persistent side effects to their healthcare provider.

Precautions[edit]

Before starting treatment with ATC-0175, patients should inform their doctor about any pre-existing medical conditions, especially those related to the liver or kidneys. It is also important to discuss any other medications or supplements being taken to avoid potential drug interactions.

Research and Development[edit]

Ongoing research is being conducted to explore the full potential of ATC-0175 in treating various types of cancer. Clinical trials are also underway to determine its efficacy and safety in combination with other antineoplastic agents.

See Also[edit]

References[edit]


External Links[edit]

-

Stub icon

This medical article is a stub. You can help WikiMD by expanding the page.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=ATC-0175&oldid=5807635"